Related by context. Frequent words. (Click for all words.) 65 tocilizumab 65 Phase 2a trial 64 phase IIa 64 decitabine 64 CERE 63 pramipexole 63 ISIS # 62 Phase 2b study 62 adalimumab 62 CA4P 62 PS# [001] 61 ACTEMRA 61 PROMACTA 61 elagolix 61 rotigotine 61 sustained virologic response 61 Phase IIa trial 61 dose cohorts 61 bronchial thermoplasty 61 Phase 2a clinical 61 rTMS 61 diabetic neuropathic pain 61 Phase 2a 61 OXi# 60 plus methotrexate 60 PRX # 60 abatacept 60 PRX# 60 LVEF 60 certolizumab pegol 60 clinically meaningful 60 azacitidine 60 TORISEL 60 HGS ETR1 60 PEG Interferon lambda 60 metastatic renal cell carcinoma 60 eltrombopag 60 talactoferrin 60 COPAXONE R 59 bosentan 59 FOLFIRI 59 Amigal 59 FTY# 59 TRIOLEX 59 ZYBRESTAT 59 XGEVA 59 phase 2a 59 BAY #-# 59 tgAAC# 59 PXD# 59 Phase IIa 59 valopicitabine 59 pazopanib 59 sunitinib 59 efficacy endpoints 59 imetelstat 59 Phase IIa clinical 59 febuxostat 58 HCV infected 58 Pharmacokinetic 58 RG# [001] 58 peginterferon 58 PF # [001] 58 IPX# 58 denufosol 58 COPAXONE ® 58 phase IIb 58 HuMax CD# 58 methylnaltrexone 58 neoadjuvant chemotherapy 58 mg BID 58 Torisel 58 INCB# [002] 58 mg dose 58 dose escalation 58 peginterferon alfa 2a 58 lacosamide 58 relapsed multiple myeloma 58 GVAX 58 dose limiting toxicities 58 Phase 2b trial 58 evaluable 58 Azixa 58 EORTC 58 HbA1c levels 57 evaluable patients 57 dimebon 57 RECIST criteria 57 dapagliflozin 57 LymphoStat B 57 davunetide 57 Phase 1b 57 events AEs 57 multiple ascending dose 57 ASA# 57 temsirolimus 57 antitumor activity 57 tumor shrinkage 57 fasting plasma glucose 57 confirmatory Phase III 57 pharmacodynamic